Akouos company information, Employees & Contact Information

Lilly to Acquire Akouos to Discover and Develop Treatments for Hearing Loss PR Newswire

Akouos Seeks to Tackle Otoferlin Gene-Mediated Hearing Loss With Phase 1/2 Clinical Trial and Associated Natural History Study CGTLive®

Akouos reports positive data from gene therapy trial for hearing loss Clinical Trials Arena

Eli Lilly to buy gene therapy company Akouos for $487 mln Reuters

Lilly to acquire hearing loss company Akouos Chemical & Engineering News

Lilly bets more than $600M on a gene therapy developer targeting hearing loss BioPharma Dive

Eli Lilly to Acquire Hearing Loss Gene Therapy Company Akouos for $487M Inside Precision Medicine

Lilly agrees to acquire gene therapy developer Akouos for $610m Pharmaceutical Technology

Lilly spies value in biotech bear market, snapping up hearing loss gene therapy player Akouos for $487M Fierce Biotech

Lilly adding hearing loss GT in Akouos buy - BioProcess Insider BioProcess International

Lilly Continues Foray into Gene Therapies with $487M Akouos Buyout BioSpace

Eli Lilly’s $487M Akouos buyout expands its gene therapy scope to hearing loss MedCity News

Lilly to Acquire Akouos for Up to $610M, Expanding Gene Therapy Focus Genetic Engineering and Biotechnology News

Lilly Acquires Hearing Loss Specialist Akouos CHEManager

Akouos (AKUS) Surges on $610M Buyout Deal With Eli Lilly Yahoo Finance

Hear here: Lilly’s Akouos gene therapy restores hearing loss in an 11-year-old BioWorld MedTech

Akouos Receives FDA Designations for AK-OTOF The Hearing Review

Akouos Stock Soars as Eli Lilly Buys Genetic Therapies Company for $610 Million Barron's

Lilly and Akouos Announce Expiration of Akouos Tender Offer PR Newswire

Otoferlin-Related Hearing Loss Gene Therapy DB-OTO Cleared for Clinical Trial Expansion to Spain CGTLive®

Akouos Inc and Blueprint Genetics Announce Resonate Program The Hearing Review

Akouos’ AK-OTOF Receives Orphan Drug Designation The Hearing Review

Investors are pouring hundreds of millions into startups working to treat hearing loss. Here are the 4 biotechs vying to disrupt the $7 billion market. businessinsider.com

Lilly pushes further into gene therapy with buy of Akouos The Pharma Letter

Akouos Appoints Two Senior Leadership Members The Hearing Review

Eli Lilly and Akouos Collaborate on Promising Gene Therapy Trial for Vestibular Schwannoma TipRanks

Eli Lilly to acquire hearing loss startup for up to $618M The Business Journals

Akouos looks to access $100m in IPO - Global Corporate Venturing

Akouos activates $105m series B - Global Corporate Venturing

Akouos aces series A with $50m - Global Corporate Venturing

Biotech Firm Akouos Signs on for 37,500 Square feet at 645 Summer Street Boston Real Estate Times

Akouos Appoints Alan Smith, Ph.D., as CTO; Saira Ramasastry Joins Board citybiz

Akouos Launches Sing Registry to Track Genetic Changes in Hearing, Treatments The Hearing Review

Musician-scientist Manny Simons and Akouos seek way to treat a gene-based hearing loss The Boston Globe

Eli Lilly concludes acquisition of Akouos Medical Dialogues

Biotech Startup Akouos Lands $7.5M To Restore & Preserve Hearing HIT Consultant

Why is Akouos (AKUS) stock gaining traction at market open today? Kalkine Media